| Oxidative stress markers in affective disorders M Siwek, M Sowa-Kućma, D Dudek, K Styczeń, B Szewczyk, K Kotarska, ... Pharmacological Reports 65 (6), 1558-1571, 2013 | 158 | 2013 |
| Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: Effects of melancholia, atypical depression, severity of … M Sowa-Kućma, K Styczeń, M Siwek, P Misztak, RJ Nowak, D Dudek, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 81, 372-383, 2018 | 93 | 2018 |
| Lipid peroxidation and immune biomarkers are associated with major depression and its phenotypes, including treatment-resistant depression and melancholia M Sowa-Kućma, K Styczeń, M Siwek, P Misztak, RJ Nowak, D Dudek, ... Neurotoxicity Research 33, 448-460, 2018 | 73 | 2018 |
| The serum zinc concentration as a potential biological marker in patients with major depressive disorder K Styczeń, M Sowa-Kućma, M Siwek, D Dudek, W Reczyński, B Szewczyk, ... Metabolic brain disease 32, 97-103, 2017 | 73 | 2017 |
| Vortioxetine: a review of the pharmacology and clinical profile of the novel antidepressant M Sowa-Kućma, P Pańczyszyn-Trzewik, P Misztak, RR Jaeschke, ... Pharmacological Reports 69, 595-601, 2017 | 72 | 2017 |
| The involvement of the GPR39-Zn (2+)-sensing receptor in the pathophysiology of depression. Studies in rodent models and suicide victims K Młyniec, U Doboszewska, B Szewczyk, M Sowa-Kućma, P Misztak, ... Neuropharmacology 79, 290-297, 2014 | 72 | 2014 |
| Associations of serum cytokine receptor levels with melancholia, staging of illness, depressive and manic phases, and severity of depression in bipolar disorder M Siwek, M Sowa-Kućma, K Styczeń, P Misztak, RJ Nowak, B Szewczyk, ... Molecular neurobiology 54, 5883-5893, 2017 | 69 | 2017 |
| Histone deacetylases (HDACs) as therapeutic target for depressive disorders P Misztak, P Pańczyszyn-Trzewik, M Sowa-Kućma Pharmacological Reports 70 (2), 398-408, 2018 | 65 | 2018 |
| Study of the serum copper levels in patients with major depressive disorder K Styczeń, M Sowa-Kućma, M Siwek, D Dudek, W Reczyński, P Misztak, ... Biological trace element research 174, 287-293, 2016 | 65 | 2016 |
| Antidepressant-like activity of magnesium in the olfactory bulbectomy model is associated with the AMPA/BDNF pathway B Pochwat, M Sowa-Kucma, K Kotarska, P Misztak, G Nowak, B Szewczyk Psychopharmacology 232, 355-367, 2015 | 63 | 2015 |
| Lurasidone: The 2016 update on the pharmacology, efficacy and safety profile RR Jaeschke, M Sowa-Kućma, P Pańczyszyn-Trzewik, P Misztak, ... Pharmacological Reports 68, 748-755, 2016 | 51 | 2016 |
| Thiobarbituric acid-reactive substances: markers of an acute episode and a late stage of bipolar disorder M Siwek, M Sowa-Kucma, K Styczen, P Misztak, B Szewczyk, ... Neuropsychobiology 73 (2), 116-122, 2016 | 47 | 2016 |
| Decreased serum zinc concentration during depressive episode in patients with bipolar disorder M Siwek, M Sowa-Kućma, K Styczeń, B Szewczyk, W Reczyński, ... Journal of Affective Disorders 190, 272-277, 2016 | 46 | 2016 |
| Zinc transporters protein level in postmortem brain of depressed subjects and suicide victims A Rafalo-Ulinska, J Piotrowska, A Kryczyk, W Opoka, M Sowa-Kucma, ... Journal of psychiatric research 83, 220-229, 2016 | 45 | 2016 |
| Alterations of bio-elements, oxidative, and inflammatory status in the zinc deficiency model in rats U Doboszewska, B Szewczyk, M Sowa-Kućma, K Noworyta-Sokołowska, ... Neurotoxicity research 29, 143-154, 2016 | 36 | 2016 |
| Epigenetic marks and their relationship with BDNF in the brain of suicide victims P Misztak, P Pańczyszyn-Trzewik, G Nowak, M Sowa-Kućma PLoS One 15 (9), e0239335, 2020 | 32 | 2020 |
| The serum concentration of copper in bipolar disorder P Misztak, W Opoka, R Topór-Mądry, G Nowak, JK Rybakowski Psychiatr. Pol 51 (3), 469-481, 2017 | 29 | 2017 |
| Involvement of extracellular signal-regulated kinase (ERK) in the short and long-lasting antidepressant-like activity of NMDA receptor antagonists (zinc and Ro 25-6981) in the … B Pochwat, A Rafało-Ulińska, H Domin, P Misztak, G Nowak, B Szewczyk Neuropharmacology 125, 333-342, 2017 | 28 | 2017 |
| Stress-induced alterations in 5-HT1A receptor transcriptional modulators NUDR and Freud-1 B Szewczyk, K Kotarska, M Daigle, P Misztak, M Sowa-Kucma, A Rafalo, ... International Journal of Neuropsychopharmacology 17 (11), 1763-1775, 2014 | 28 | 2014 |
| The serum concentration of magnesium as a potential state marker in patients with diagnosis of bipolar disorder P Misztak, W Opoka, R Topór-Mądry Psychiatr Pol 49 (6), 1277-87, 2015 | 22 | 2015 |
